Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Biopharmaceutical CMO And CRO Market Growth Potential: How Will Market Size Shift Through 2030?
The biopharmaceutical cmo and cro market size has shown robust expansion in recent years. It is anticipated to grow from $35.6 billion in 2025 to $38.01 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.8%. This historical growth can be primarily linked to the increasing complexity involved in biologic drug development, the rising R&D expenses for biopharmaceutical companies, the broader scope of clinical trial activities, advancements in biosimilar development, and the presence of specialized contract service providers.
The biopharmaceutical cmo and cro market size is anticipated to experience robust expansion over the next few years, reaching $48.79 billion by 2030, with a compound annual growth rate (CAGR) of 6.4%. This projected growth is driven by increasing demand for advanced biologics manufacturing, rising investments in cell and gene therapies, the expansion of global clinical trial pipelines, a growing focus on speed-to-market strategies, and the increasing adoption of digitalized CRO services. Major trends expected during this period include increasing outsourcing of biologic drug manufacturing, a rising demand for end-to-end contract research services, a growing emphasis on flexible manufacturing capacity, the expansion of cell and gene therapy development support, and an enhanced focus on regulatory compliance services.
Get A Free Sample Report With In-Depth Market Insights:
Biopharmaceutical CMO And CRO Market Growth Factors Behind Sustained Expansion
The increasing investment in research and development is projected to boost the expansion of the biopharmaceutical CMO and CRO market in the future. This surge in R&D funding is attributed to various factors, including the demand for innovation, competitive pressures, the necessity to address evolving market requirements, and government incentives. Such investments empower CMOs and CROs to develop superior manufacturing methods and research procedures, thereby enhancing their capabilities and operational efficiency. This commitment to innovation attracts and retains clients by providing cutting-edge solutions while ensuring regulatory compliance. For instance, in September 2025, Eurostat, the Luxembourg-based statistical agency, reported that the EU spent approximately $456 billion USD on research and development (R&D) in 2023 (€389 billion), with R&D expenditure relative to GDP rising to 2.26%, up from 2.22% in the preceding year. Thus, the growing investment in research and development is propelling the growth of the biopharmaceutical CMO and CRO market.
Biopharmaceutical CMO And CRO Market Segments: Where Is Growth Concentrated?
The biopharmaceutical cmo and cro market covered in this report is segmented –
1) By Product: Biologics, Biosimilars
2) By Service Type: Contract Manufacturing, Contract Research
3) By Source: Mammalian, Non-Mammalian
Subsegments:
1) By Biologics: Monoclonal Antibodies (mAbs), Vaccines, Recombinant Proteins, Cell and Gene Therapies, Antibody-Drug Conjugates (ADCs), Therapeutic Enzymes
2) By Biosimilars: Biosimilar Monoclonal Antibodies, Biosimilar Insulins, Biosimilar Growth Hormones, Biosimilar Erythropoietins, Biosimilar Granulocyte Colony-Stimulating Factors (G-CSFs)
Biopharmaceutical CMO And CRO Market Industry Trends Fueling Future Revenue Growth
Leading entities within the biopharmaceutical CMO and CRO market are forging strategic alliances to enhance their service offerings, boost operational efficiencies, and accelerate drug development for biopharmaceutical companies. These strategic collaborations represent a process where organizations leverage each other’s strengths and resources to achieve mutual benefits and success. For example, in June 2024, Abzena plc., a biopharmaceutical firm located in the UK, entered into a partnership with Argonaut Manufacturing Services Inc., a US-based contract manufacturing organization (CMO), with the goal of integrating drug development and manufacturing solutions for clients. Through this joint effort, they intend to offer expedited, comprehensive drug development and manufacturing solutions designed to improve efficiency, reduce expenses, and streamline biopharmaceutical production for their clientele.
Biopharmaceutical CMO And CRO Market Key Participants And Competitive Landscape
Major companies operating in the biopharmaceutical cmo and cro market are Thermo Fisher Scientific Inc., Boehringer Ingelheim International GmbH, Eurofins Scientific SE, Lonza Group AG, Syneos Health Inc., Catalent Inc., Charles River Laboratories International Inc., Parexel International (MA) Corporation, Samsung Biologics Co. Ltd., CELLTRION INC., Medpace Holdings Inc., Fujifilm Diosynth Biotechnologies UK Limited, Almac Group, Pharmaron Beijing Co. Ltd., Worldwide Clinical Trials, KBI Biopharma, Inotiv Inc., Caidya, Rentschler Biopharma SE, Celerion Inc., TFS HEALTHCARE LIMITED
View The Full Biopharmaceutical CMO And CRO Market Report:
Biopharmaceutical CMO And CRO Market Top Region By Revenue And Market Share
North America was the largest region in the biopharmaceutical CMO and CRO market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical cmo and cro market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model









